Common Contracts
3 similar Merger Agreement contracts by Transcept Pharmaceuticals Inc
Transcept Pharmaceuticals and Paratek Pharmaceuticals Sign Merger AgreementMerger Agreement • July 17th, 2014
Merger to result in NASDAQ−listed biopharmaceutical company whose lead asset is a novel Phase 3−ready, oral and intravenous antibiotic drug candidate designed to address the treatment needs of patients with serious community−acquired bacterial infections.
Transcept Pharmaceuticals and Paratek Pharmaceuticals Sign Merger AgreementMerger Agreement • July 1st, 2014
Merger to result in NASDAQ-listed biopharmaceutical company whose lead asset is a novel Phase 3-ready, oral and intravenous antibiotic drug candidate designed to address the treatment needs of patients with serious community-acquired bacterial infections.
Transcept Pharmaceuticals and Paratek Pharmaceuticals Sign Merger AgreementMerger Agreement • July 1st, 2014 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations
Merger to result in NASDAQ-listed biopharmaceutical company whose lead asset is a novel Phase 3-ready, oral and intravenous antibiotic drug candidate designed to address the treatment needs of patients with serious community-acquired bacterial infections.
